NEW YORK — Any attempt by the Alan Guttmacher Institute (AGI) to claim neutrality has been put aside by the announcement of its appointment of Sharon Camp as President and CEO. Camp will begin her new role with AGI in January. She is currently President and CEO of Women's Capital Corporation, a Planned Parenthood run group set up to market the abortifacient morning-after-pill Plan-B.
Under Camp’s leadership, the public can expect the same biased and misleading policy analysis and research AGI is known for. Camp was well known for her refusal to admit the morning after pill was abortifacient. When queried, she would falsely refer to Plan-B as “the anti-abortion pill.”
(This update courtesy of LifeSiteNews.com.)
